BLGO - BioLargo, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue1,364516281.106127.582
Cost of Revenue743323105.87762.067
Gross Profit621193175.22965.515
Operating Expenses
Research Development1,7191,6301,381.956684.554
Selling General and Administrative5,2644,4293,714.3983,551.522
Non Recurring----
Others-73-71-71-71
Total Operating Expenses7,7036,3415,215.9674,309.063
Operating Income or Loss-6,339-5,825-4,934.861-4,181.481
Income from Continuing Operations
Total Other Income/Expenses Net-4,357-3,722-3,139.474-895.549
Earnings Before Interest and Taxes-6,339-5,825-4,934.861-4,181.481
Interest Expense-3,494-3,862-3,129.104-994.671
Income Before Tax-10,696-9,547-8,074.335-5,077.03
Income Tax Expense----
Minority Interest373695554.969789.573
Net Income From Continuing Ops-10,696-9,547-8,074.335-5,077.03
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-10,221-9,118-7,839.731-5,055.976
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-10,221-9,118-7,839.731-5,055.976